Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
6(75.0%)
Phase 2
2(25.0%)
8Total
Phase 1(6)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07737496Phase 1Not Yet Recruiting

A Study of HW243040 in Healthy Participants

Role: lead

NCT07719920Phase 1Not Yet Recruiting

A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors

Role: lead

NCT07513454Phase 2Not Yet Recruiting

A Phase 2 Study of HW211026

Role: lead

NCT07593690Phase 1Not Yet Recruiting

A Phase I Study of HW241045 in Healthy Subjects

Role: lead

NCT07493031Phase 1Not Yet Recruiting

A PhaseⅠ Study of HW252001 in Healthy Subjects

Role: lead

NCT07483489Phase 2Not Yet Recruiting

A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).

Role: lead

NCT07448194Phase 1Recruiting

A Phase Ia Clinical Trial of HW241045

Role: lead

NCT07318675Phase 1Recruiting

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Role: lead

All 8 trials loaded